[
  {
    "title": "AstraZeneca Stock Tumbles On $39 Billion Alexion Pharmaceuticals Takeover - Report Door",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "AstraZeneca Stock Tumbles On $39 Billion Alexion Pharmaceuticals Takeover - Report Door"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.reportdoor.com/astrazeneca-stock-tumbles-on-39-billion-alexion-pharmaceuticals-takeover/"
      }
    ],
    "link": "https://www.reportdoor.com/astrazeneca-stock-tumbles-on-39-billion-alexion-pharmaceuticals-takeover/",
    "id": "52781240492837",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:45:46 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      45,
      46,
      0,
      349,
      0
    ],
    "summary": "<ol><li><a href=\"https://www.reportdoor.com/astrazeneca-stock-tumbles-on-39-billion-alexion-pharmaceuticals-takeover/\" target=\"_blank\">AstraZeneca Stock Tumbles On $39 Billion Alexion Pharmaceuticals Takeover</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Report Door</font></li><li><a href=\"https://www.journalinquirer.com/business/new-haven-born-alexion-to-be-sold-for-39b/article_152d5660-3e2c-11eb-a7ca-8f9cfe1ec480.html\" target=\"_blank\">New Haven-born Alexion to be sold for $39B</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Journal Inquirer</font></li><li><a href=\"https://www.fiercepharma.com/pharma/astrazeneca-expected-acquirer-for-alexion-39b-deal-beneficial-to-both-drugmakers\" target=\"_blank\">Does AstraZeneca get enough out of its $39B deal for Alexion\u2014and vice versa?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FiercePharma</font></li><li><a href=\"https://www.nasdaq.com/articles/wall-street-surges-on-covid-19-vaccine-approval-2020-12-14\" target=\"_blank\">Wall Street Surges on COVID-19 Vaccine Approval</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font></li><li><a href=\"https://seekingalpha.com/article/4394612-astrazeneca-starting-acquisition-boom\" target=\"_blank\">AstraZeneca: Starting The Acquisition Boom (NASDAQ:AZN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWlseHR5NGtZQU1FWl9UTGJ1azdQRXZLQUFQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<ol><li><a href=\"https://www.reportdoor.com/astrazeneca-stock-tumbles-on-39-billion-alexion-pharmaceuticals-takeover/\" target=\"_blank\">AstraZeneca Stock Tumbles On $39 Billion Alexion Pharmaceuticals Takeover</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Report Door</font></li><li><a href=\"https://www.journalinquirer.com/business/new-haven-born-alexion-to-be-sold-for-39b/article_152d5660-3e2c-11eb-a7ca-8f9cfe1ec480.html\" target=\"_blank\">New Haven-born Alexion to be sold for $39B</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Journal Inquirer</font></li><li><a href=\"https://www.fiercepharma.com/pharma/astrazeneca-expected-acquirer-for-alexion-39b-deal-beneficial-to-both-drugmakers\" target=\"_blank\">Does AstraZeneca get enough out of its $39B deal for Alexion\u2014and vice versa?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FiercePharma</font></li><li><a href=\"https://www.nasdaq.com/articles/wall-street-surges-on-covid-19-vaccine-approval-2020-12-14\" target=\"_blank\">Wall Street Surges on COVID-19 Vaccine Approval</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font></li><li><a href=\"https://seekingalpha.com/article/4394612-astrazeneca-starting-acquisition-boom\" target=\"_blank\">AstraZeneca: Starting The Acquisition Boom (NASDAQ:AZN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWlseHR5NGtZQU1FWl9UTGJ1azdQRXZLQUFQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>"
    },
    "source": {
      "href": "https://www.reportdoor.com",
      "title": "Report Door"
    },
    "sub_articles": [
      {
        "url": "https://www.reportdoor.com/astrazeneca-stock-tumbles-on-39-billion-alexion-pharmaceuticals-takeover/",
        "title": "AstraZeneca Stock Tumbles On $39 Billion Alexion Pharmaceuticals Takeover",
        "publisher": "Report Door"
      },
      {
        "url": "https://www.journalinquirer.com/business/new-haven-born-alexion-to-be-sold-for-39b/article_152d5660-3e2c-11eb-a7ca-8f9cfe1ec480.html",
        "title": "New Haven-born Alexion to be sold for $39B",
        "publisher": "Journal Inquirer"
      },
      {
        "url": "https://www.fiercepharma.com/pharma/astrazeneca-expected-acquirer-for-alexion-39b-deal-beneficial-to-both-drugmakers",
        "title": "Does AstraZeneca get enough out of its $39B deal for Alexion\u2014and vice versa?",
        "publisher": "FiercePharma"
      },
      {
        "url": "https://www.nasdaq.com/articles/wall-street-surges-on-covid-19-vaccine-approval-2020-12-14",
        "title": "Wall Street Surges on COVID-19 Vaccine Approval",
        "publisher": "Nasdaq"
      },
      {
        "url": "https://seekingalpha.com/article/4394612-astrazeneca-starting-acquisition-boom",
        "title": "AstraZeneca: Starting The Acquisition Boom (NASDAQ:AZN)",
        "publisher": "Seeking Alpha"
      }
    ]
  },
  {
    "title": "Thinking about buying stock in Pfizer, Moderna, Arvinas, Veru, or Alexion Pharmaceuticals? - GuruFocus.com",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Thinking about buying stock in Pfizer, Moderna, Arvinas, Veru, or Alexion Pharmaceuticals? - GuruFocus.com"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.gurufocus.com/news/1310706/thinking-about-buying-stock-in-pfizer-moderna-arvinas-veru-or-alexion-pharmaceuticals"
      }
    ],
    "link": "https://www.gurufocus.com/news/1310706/thinking-about-buying-stock-in-pfizer-moderna-arvinas-veru-or-alexion-pharmaceuticals",
    "id": "CBMifGh0dHBzOi8vd3d3Lmd1cnVmb2N1cy5jb20vbmV3cy8xMzEwNzA2L3RoaW5raW5nLWFib3V0LWJ1eWluZy1zdG9jay1pbi1wZml6ZXItbW9kZXJuYS1hcnZpbmFzLXZlcnUtb3ItYWxleGlvbi1waGFybWFjZXV0aWNhbHPSAQA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:03:59 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      3,
      59,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.gurufocus.com/news/1310706/thinking-about-buying-stock-in-pfizer-moderna-arvinas-veru-or-alexion-pharmaceuticals\" target=\"_blank\">Thinking about buying stock in Pfizer, Moderna, Arvinas, Veru, or Alexion Pharmaceuticals?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus.com</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.gurufocus.com/news/1310706/thinking-about-buying-stock-in-pfizer-moderna-arvinas-veru-or-alexion-pharmaceuticals\" target=\"_blank\">Thinking about buying stock in Pfizer, Moderna, Arvinas, Veru, or Alexion Pharmaceuticals?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus.com</font>"
    },
    "source": {
      "href": "https://www.gurufocus.com",
      "title": "GuruFocus.com"
    },
    "sub_articles": []
  },
  {
    "title": "Monday's ETF Movers: XBI, IXC - Nasdaq",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Monday's ETF Movers: XBI, IXC - Nasdaq"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.nasdaq.com/articles/mondays-etf-movers%3A-xbi-ixc-2020-12-14"
      }
    ],
    "link": "https://www.nasdaq.com/articles/mondays-etf-movers%3A-xbi-ixc-2020-12-14",
    "id": "CAIiEC33nTXb_w9iUKVl3fRXihMqMwgEKioIACIQT4VDYmxpaDN7y5JvscS9FioUCAoiEE-FQ2JsaWgze8uSb7HEvRYw6_HMBg",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:12:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      12,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.nasdaq.com/articles/mondays-etf-movers%3A-xbi-ixc-2020-12-14\" target=\"_blank\">Monday's ETF Movers: XBI, IXC</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.nasdaq.com/articles/mondays-etf-movers%3A-xbi-ixc-2020-12-14\" target=\"_blank\">Monday's ETF Movers: XBI, IXC</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>"
    },
    "source": {
      "href": "https://www.nasdaq.com",
      "title": "Nasdaq"
    },
    "sub_articles": []
  },
  {
    "title": "52 Stocks Moving In Monday's Mid-Day Session - Benzinga",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "52 Stocks Moving In Monday's Mid-Day Session - Benzinga"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.benzinga.com/news/20/12/18778078/52-stocks-moving-in-mondays-mid-day-session"
      }
    ],
    "link": "https://www.benzinga.com/news/20/12/18778078/52-stocks-moving-in-mondays-mid-day-session",
    "id": "CBMiWGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9uZXdzLzIwLzEyLzE4Nzc4MDc4LzUyLXN0b2Nrcy1tb3ZpbmctaW4tbW9uZGF5cy1taWQtZGF5LXNlc3Npb27SAQA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:02:42 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      2,
      42,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.benzinga.com/news/20/12/18778078/52-stocks-moving-in-mondays-mid-day-session\" target=\"_blank\">52 Stocks Moving In Monday's Mid-Day Session</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.benzinga.com/news/20/12/18778078/52-stocks-moving-in-mondays-mid-day-session\" target=\"_blank\">52 Stocks Moving In Monday's Mid-Day Session</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>"
    },
    "source": {
      "href": "https://www.benzinga.com",
      "title": "Benzinga"
    },
    "sub_articles": []
  },
  {
    "title": "Boutique Firms Steal the Show on Year's Top Health-Care Deal - BloombergQuint",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Boutique Firms Steal the Show on Year's Top Health-Care Deal - BloombergQuint"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.bloombergquint.com/business/boutique-firms-steal-the-show-on-year-s-top-health-care-deal"
      }
    ],
    "link": "https://www.bloombergquint.com/business/boutique-firms-steal-the-show-on-year-s-top-health-care-deal",
    "id": "CAIiELZv6q9_0bpGVuX0kCblKvAqGQgEKhAIACoHCAowqvSQCzD0nKUDMPOf6AY",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:52:48 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      52,
      48,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.bloombergquint.com/business/boutique-firms-steal-the-show-on-year-s-top-health-care-deal\" target=\"_blank\">Boutique Firms Steal the Show on Year's Top Health-Care Deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BloombergQuint</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.bloombergquint.com/business/boutique-firms-steal-the-show-on-year-s-top-health-care-deal\" target=\"_blank\">Boutique Firms Steal the Show on Year's Top Health-Care Deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BloombergQuint</font>"
    },
    "source": {
      "href": "https://www.bloombergquint.com",
      "title": "BloombergQuint"
    },
    "sub_articles": []
  },
  {
    "title": "Astrazeneca/Alexion merger could drive more deals: Piper Sandler - Seeking Alpha",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Astrazeneca/Alexion merger could drive more deals: Piper Sandler - Seeking Alpha"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://seekingalpha.com/news/3644124-astrazeneca-alexion-merger-drive-deals-piper-sandler"
      }
    ],
    "link": "https://seekingalpha.com/news/3644124-astrazeneca-alexion-merger-drive-deals-piper-sandler",
    "id": "CBMiWmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9uZXdzLzM2NDQxMjQtYXN0cmF6ZW5lY2EtYWxleGlvbi1tZXJnZXItZHJpdmUtZGVhbHMtcGlwZXItc2FuZGxlctIBXmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hbXAvbmV3cy8zNjQ0MTI0LWFzdHJhemVuZWNhLWFsZXhpb24tbWVyZ2VyLWRyaXZlLWRlYWxzLXBpcGVyLXNhbmRsZXI",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:02:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      2,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://seekingalpha.com/news/3644124-astrazeneca-alexion-merger-drive-deals-piper-sandler\" target=\"_blank\">Astrazeneca/Alexion merger could drive more deals: Piper Sandler</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://seekingalpha.com/news/3644124-astrazeneca-alexion-merger-drive-deals-piper-sandler\" target=\"_blank\">Astrazeneca/Alexion merger could drive more deals: Piper Sandler</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>"
    },
    "source": {
      "href": "https://seekingalpha.com",
      "title": "Seeking Alpha"
    },
    "sub_articles": []
  },
  {
    "title": "Dow Jones Jumps 300 Points Before Paring Gains As Vaccine Rollout Beings; Nasdaq Rallies - Investor's Business Daily",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Dow Jones Jumps 300 Points Before Paring Gains As Vaccine Rollout Beings; Nasdaq Rallies - Investor's Business Daily"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.investors.com/market-trend/stock-market-today/dow-jones-jumps-300-points-pares-gains-vaccine-rollout-begins-nasdaq-rallies/"
      }
    ],
    "link": "https://www.investors.com/market-trend/stock-market-today/dow-jones-jumps-300-points-pares-gains-vaccine-rollout-begins-nasdaq-rallies/",
    "id": "CAIiECuEZihFGff5CrCVkeWjwB0qGQgEKhAIACoHCAowzpuGCzCQ9YMDMPqDuAY",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:19:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      19,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.investors.com/market-trend/stock-market-today/dow-jones-jumps-300-points-pares-gains-vaccine-rollout-begins-nasdaq-rallies/\" target=\"_blank\">Dow Jones Jumps 300 Points Before Paring Gains As Vaccine Rollout Beings; Nasdaq Rallies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.investors.com/market-trend/stock-market-today/dow-jones-jumps-300-points-pares-gains-vaccine-rollout-begins-nasdaq-rallies/\" target=\"_blank\">Dow Jones Jumps 300 Points Before Paring Gains As Vaccine Rollout Beings; Nasdaq Rallies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>"
    },
    "source": {
      "href": "https://www.investors.com",
      "title": "Investor's Business Daily"
    },
    "sub_articles": []
  },
  {
    "title": "British mid-caps advance as Brexit talks continue - Financial Post",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "British mid-caps advance as Brexit talks continue - Financial Post"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://financialpost.com/pmn/business-pmn/british-mid-caps-advance-as-brexit-talks-continue"
      }
    ],
    "link": "https://financialpost.com/pmn/business-pmn/british-mid-caps-advance-as-brexit-talks-continue",
    "id": "CBMiXGh0dHBzOi8vZmluYW5jaWFscG9zdC5jb20vcG1uL2J1c2luZXNzLXBtbi9icml0aXNoLW1pZC1jYXBzLWFkdmFuY2UtYXMtYnJleGl0LXRhbGtzLWNvbnRpbnVl0gEA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:03:37 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      3,
      37,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://financialpost.com/pmn/business-pmn/british-mid-caps-advance-as-brexit-talks-continue\" target=\"_blank\">British mid-caps advance as Brexit talks continue</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Financial Post</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://financialpost.com/pmn/business-pmn/british-mid-caps-advance-as-brexit-talks-continue\" target=\"_blank\">British mid-caps advance as Brexit talks continue</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Financial Post</font>"
    },
    "source": {
      "href": "https://financialpost.com",
      "title": "Financial Post"
    },
    "sub_articles": []
  },
  {
    "title": "Global Pancreatic Enzyme Replacement Therapy Market To Witness A Pronounce Growth During 2027\u2013 Top Key Players Like Biomarin Pharmaceutical Inc., AbbVie Inc, Alexion Pharmaceuticals Inc - SpinazzolaLive",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Global Pancreatic Enzyme Replacement Therapy Market To Witness A Pronounce Growth During 2027\u2013 Top Key Players Like Biomarin Pharmaceutical Inc., AbbVie Inc, Alexion Pharmaceuticals Inc - SpinazzolaLive"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.spinazzolalive.it/global-pancreatic-enzyme-replacement-therapy-market-to-witness-a-pronounce-growth-during-2027-top-key-players-like-biomarin-pharmaceutical-inc-abbvie-inc-alexion-pharmaceuticals-inc/"
      }
    ],
    "link": "https://www.spinazzolalive.it/global-pancreatic-enzyme-replacement-therapy-market-to-witness-a-pronounce-growth-during-2027-top-key-players-like-biomarin-pharmaceutical-inc-abbvie-inc-alexion-pharmaceuticals-inc/",
    "id": "CBMi1AFodHRwczovL3d3dy5zcGluYXp6b2xhbGl2ZS5pdC9nbG9iYWwtcGFuY3JlYXRpYy1lbnp5bWUtcmVwbGFjZW1lbnQtdGhlcmFweS1tYXJrZXQtdG8td2l0bmVzcy1hLXByb25vdW5jZS1ncm93dGgtZHVyaW5nLTIwMjctdG9wLWtleS1wbGF5ZXJzLWxpa2UtYmlvbWFyaW4tcGhhcm1hY2V1dGljYWwtaW5jLWFiYnZpZS1pbmMtYWxleGlvbi1waGFybWFjZXV0aWNhbHMtaW5jL9IBAA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:30:04 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      30,
      4,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.spinazzolalive.it/global-pancreatic-enzyme-replacement-therapy-market-to-witness-a-pronounce-growth-during-2027-top-key-players-like-biomarin-pharmaceutical-inc-abbvie-inc-alexion-pharmaceuticals-inc/\" target=\"_blank\">Global Pancreatic Enzyme Replacement Therapy Market To Witness A Pronounce Growth During 2027\u2013 Top Key Players Like Biomarin Pharmaceutical Inc., AbbVie Inc, Alexion Pharmaceuticals Inc</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">SpinazzolaLive</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.spinazzolalive.it/global-pancreatic-enzyme-replacement-therapy-market-to-witness-a-pronounce-growth-during-2027-top-key-players-like-biomarin-pharmaceutical-inc-abbvie-inc-alexion-pharmaceuticals-inc/\" target=\"_blank\">Global Pancreatic Enzyme Replacement Therapy Market To Witness A Pronounce Growth During 2027\u2013 Top Key Players Like Biomarin Pharmaceutical Inc., AbbVie Inc, Alexion Pharmaceuticals Inc</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">SpinazzolaLive</font>"
    },
    "source": {
      "href": "https://www.spinazzolalive.it",
      "title": "SpinazzolaLive"
    },
    "sub_articles": []
  },
  {
    "title": "Dow, S&P 500 trim gains as oil reverses course - Fox Business",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Dow, S&P 500 trim gains as oil reverses course - Fox Business"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.foxbusiness.com/markets/us-stocks-dec-14-2020"
      }
    ],
    "link": "https://www.foxbusiness.com/markets/us-stocks-dec-14-2020",
    "id": "CBMiOWh0dHBzOi8vd3d3LmZveGJ1c2luZXNzLmNvbS9tYXJrZXRzL3VzLXN0b2Nrcy1kZWMtMTQtMjAyMNIBPWh0dHBzOi8vd3d3LmZveGJ1c2luZXNzLmNvbS9tYXJrZXRzL3VzLXN0b2Nrcy1kZWMtMTQtMjAyMC5hbXA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:09:50 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      9,
      50,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.foxbusiness.com/markets/us-stocks-dec-14-2020\" target=\"_blank\">Dow, S&P 500 trim gains as oil reverses course</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fox Business</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.foxbusiness.com/markets/us-stocks-dec-14-2020\" target=\"_blank\">Dow, S&P 500 trim gains as oil reverses course</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fox Business</font>"
    },
    "source": {
      "href": "https://www.foxbusiness.com",
      "title": "Fox Business"
    },
    "sub_articles": []
  },
  {
    "title": "FRN Variable Rate Fix - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "FRN Variable Rate Fix - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/news/frn-variable-rate-fix-171900962.html"
      }
    ],
    "link": "https://finance.yahoo.com/news/frn-variable-rate-fix-171900962.html",
    "id": "CBMiQ2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9mcm4tdmFyaWFibGUtcmF0ZS1maXgtMTcxOTAwOTYyLmh0bWzSAUtodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9mcm4tdmFyaWFibGUtcmF0ZS1maXgtMTcxOTAwOTYyLmh0bWw",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:19:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      19,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://finance.yahoo.com/news/frn-variable-rate-fix-171900962.html\" target=\"_blank\">FRN Variable Rate Fix</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://finance.yahoo.com/news/frn-variable-rate-fix-171900962.html\" target=\"_blank\">FRN Variable Rate Fix</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": []
  },
  {
    "title": "Erdogan says Turkey working to lower rates to appropriate levels - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Erdogan says Turkey working to lower rates to appropriate levels - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/news/erdogan-says-turkey-working-lower-171147493.html"
      }
    ],
    "link": "https://finance.yahoo.com/news/erdogan-says-turkey-working-lower-171147493.html",
    "id": "CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9lcmRvZ2FuLXNheXMtdHVya2V5LXdvcmtpbmctbG93ZXItMTcxMTQ3NDkzLmh0bWzSAVdodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9lcmRvZ2FuLXNheXMtdHVya2V5LXdvcmtpbmctbG93ZXItMTcxMTQ3NDkzLmh0bWw",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:11:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      11,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://finance.yahoo.com/news/erdogan-says-turkey-working-lower-171147493.html\" target=\"_blank\">Erdogan says Turkey working to lower rates to appropriate levels</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://finance.yahoo.com/news/erdogan-says-turkey-working-lower-171147493.html\" target=\"_blank\">Erdogan says Turkey working to lower rates to appropriate levels</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": []
  },
  {
    "title": "Participation Notification by Blackrock Inc. - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Participation Notification by Blackrock Inc. - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/news/participation-notification-blackrock-inc-164500958.html"
      }
    ],
    "link": "https://finance.yahoo.com/news/participation-notification-blackrock-inc-164500958.html",
    "id": "CBMiVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9wYXJ0aWNpcGF0aW9uLW5vdGlmaWNhdGlvbi1ibGFja3JvY2staW5jLTE2NDUwMDk1OC5odG1s0gFeaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvcGFydGljaXBhdGlvbi1ub3RpZmljYXRpb24tYmxhY2tyb2NrLWluYy0xNjQ1MDA5NTguaHRtbA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:45:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      45,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://finance.yahoo.com/news/participation-notification-blackrock-inc-164500958.html\" target=\"_blank\">Participation Notification by Blackrock Inc.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://finance.yahoo.com/news/participation-notification-blackrock-inc-164500958.html\" target=\"_blank\">Participation Notification by Blackrock Inc.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": []
  },
  {
    "title": "InventHelp Inventor Develops Distinctive Beard Designer (DNV-189) - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "InventHelp Inventor Develops Distinctive Beard Designer (DNV-189) - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/news/inventhelp-inventor-develops-distinctive-beard-164500555.html"
      }
    ],
    "link": "https://finance.yahoo.com/news/inventhelp-inventor-develops-distinctive-beard-164500555.html",
    "id": "CBMiXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9pbnZlbnRoZWxwLWludmVudG9yLWRldmVsb3BzLWRpc3RpbmN0aXZlLWJlYXJkLTE2NDUwMDU1NS5odG1s0gFkaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvaW52ZW50aGVscC1pbnZlbnRvci1kZXZlbG9wcy1kaXN0aW5jdGl2ZS1iZWFyZC0xNjQ1MDA1NTUuaHRtbA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:45:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      45,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://finance.yahoo.com/news/inventhelp-inventor-develops-distinctive-beard-164500555.html\" target=\"_blank\">InventHelp Inventor Develops Distinctive Beard Designer (DNV-189)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://finance.yahoo.com/news/inventhelp-inventor-develops-distinctive-beard-164500555.html\" target=\"_blank\">InventHelp Inventor Develops Distinctive Beard Designer (DNV-189)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": []
  },
  {
    "title": "Volkswagen CEO set to survive power struggle - sources - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Volkswagen CEO set to survive power struggle - sources - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/news/volkswagen-ceo-set-survive-power-165557010.html"
      }
    ],
    "link": "https://finance.yahoo.com/news/volkswagen-ceo-set-survive-power-165557010.html",
    "id": "CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92b2xrc3dhZ2VuLWNlby1zZXQtc3Vydml2ZS1wb3dlci0xNjU1NTcwMTAuaHRtbNIBVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL3ZvbGtzd2FnZW4tY2VvLXNldC1zdXJ2aXZlLXBvd2VyLTE2NTU1NzAxMC5odG1s",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:55:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      55,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://finance.yahoo.com/news/volkswagen-ceo-set-survive-power-165557010.html\" target=\"_blank\">Volkswagen CEO set to survive power struggle - sources</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://finance.yahoo.com/news/volkswagen-ceo-set-survive-power-165557010.html\" target=\"_blank\">Volkswagen CEO set to survive power struggle - sources</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": []
  },
  {
    "title": "European shares cheer Brexit trade talks extension; AstraZeneca drops - Marketscreener.com",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "European shares cheer Brexit trade talks extension; AstraZeneca drops - Marketscreener.com"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.marketscreener.com/news/latest/European-shares-cheer-Brexit-trade-talks-extension-AstraZeneca-drops--32003660/"
      }
    ],
    "link": "https://www.marketscreener.com/news/latest/European-shares-cheer-Brexit-trade-talks-extension-AstraZeneca-drops--32003660/",
    "id": "CAIiEKbxbqYBK9shHRW41BKh69YqGQgEKhAIACoHCAowxZ6VCzC-_6oDMMvTxQY",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:05:28 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      5,
      28,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.marketscreener.com/news/latest/European-shares-cheer-Brexit-trade-talks-extension-AstraZeneca-drops--32003660/\" target=\"_blank\">European shares cheer Brexit trade talks extension; AstraZeneca drops</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Marketscreener.com</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.marketscreener.com/news/latest/European-shares-cheer-Brexit-trade-talks-extension-AstraZeneca-drops--32003660/\" target=\"_blank\">European shares cheer Brexit trade talks extension; AstraZeneca drops</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Marketscreener.com</font>"
    },
    "source": {
      "href": "https://www.marketscreener.com",
      "title": "Marketscreener.com"
    },
    "sub_articles": []
  },
  {
    "title": "Equities higher on UK-EU trade hopes and US stimulus optimism - CMC Markets",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Equities higher on UK-EU trade hopes and US stimulus optimism - CMC Markets"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.cmcmarkets.com/en/news-and-analysis/equities-higher-on-uk-eu-trade-hopes-and-us-stimulus-optimism"
      }
    ],
    "link": "https://www.cmcmarkets.com/en/news-and-analysis/equities-higher-on-uk-eu-trade-hopes-and-us-stimulus-optimism",
    "id": "CBMibWh0dHBzOi8vd3d3LmNtY21hcmtldHMuY29tL2VuL25ld3MtYW5kLWFuYWx5c2lzL2VxdWl0aWVzLWhpZ2hlci1vbi11ay1ldS10cmFkZS1ob3Blcy1hbmQtdXMtc3RpbXVsdXMtb3B0aW1pc23SAXFodHRwczovL3d3dy5jbWNtYXJrZXRzLmNvbS9lbi9uZXdzLWFuZC1hbmFseXNpcy9lcXVpdGllcy1oaWdoZXItb24tdWstZXUtdHJhZGUtaG9wZXMtYW5kLXVzLXN0aW11bHVzLW9wdGltaXNtX2FtcA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:47:17 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      47,
      17,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.cmcmarkets.com/en/news-and-analysis/equities-higher-on-uk-eu-trade-hopes-and-us-stimulus-optimism\" target=\"_blank\">Equities higher on UK-EU trade hopes and US stimulus optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CMC Markets</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.cmcmarkets.com/en/news-and-analysis/equities-higher-on-uk-eu-trade-hopes-and-us-stimulus-optimism\" target=\"_blank\">Equities higher on UK-EU trade hopes and US stimulus optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CMC Markets</font>"
    },
    "source": {
      "href": "https://www.cmcmarkets.com",
      "title": "CMC Markets"
    },
    "sub_articles": []
  },
  {
    "title": "SPACs may spur $300B in M&A activity over the next 2 years: Goldman Sachs - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "SPACs may spur $300B in M&A activity over the next 2 years: Goldman Sachs - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/video/spacs-may-spur-300b-m-164635478.html"
      }
    ],
    "link": "https://finance.yahoo.com/video/spacs-may-spur-300b-m-164635478.html",
    "id": "CBMiRGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vdmlkZW8vc3BhY3MtbWF5LXNwdXItMzAwYi1tLTE2NDYzNTQ3OC5odG1s0gFMaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL3ZpZGVvL3NwYWNzLW1heS1zcHVyLTMwMGItbS0xNjQ2MzU0NzguaHRtbA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:46:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      46,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://finance.yahoo.com/video/spacs-may-spur-300b-m-164635478.html\" target=\"_blank\">SPACs may spur $300B in M&A activity over the next 2 years: Goldman Sachs</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://finance.yahoo.com/video/spacs-may-spur-300b-m-164635478.html\" target=\"_blank\">SPACs may spur $300B in M&A activity over the next 2 years: Goldman Sachs</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": []
  },
  {
    "title": "Wall Street rallies following worst week since Halloween - The Tri-City News",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Wall Street rallies following worst week since Halloween - The Tri-City News"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.tricitynews.com/world-news/wall-street-rallies-following-worst-week-since-halloween-3181668"
      }
    ],
    "link": "https://www.tricitynews.com/world-news/wall-street-rallies-following-worst-week-since-halloween-3181668",
    "id": "CBMiZ2h0dHBzOi8vd3d3LnRyaWNpdHluZXdzLmNvbS93b3JsZC1uZXdzL3dhbGwtc3RyZWV0LXJhbGxpZXMtZm9sbG93aW5nLXdvcnN0LXdlZWstc2luY2UtaGFsbG93ZWVuLTMxODE2NjjSAQA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 17:06:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      17,
      6,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.tricitynews.com/world-news/wall-street-rallies-following-worst-week-since-halloween-3181668\" target=\"_blank\">Wall Street rallies following worst week since Halloween</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Tri-City News</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.tricitynews.com/world-news/wall-street-rallies-following-worst-week-since-halloween-3181668\" target=\"_blank\">Wall Street rallies following worst week since Halloween</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Tri-City News</font>"
    },
    "source": {
      "href": "https://www.tricitynews.com",
      "title": "The Tri-City News"
    },
    "sub_articles": []
  },
  {
    "title": "Rare Disease Drug Market \u2013 Major Technology Giants in Buzz Again | Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Alexion Pharmaceuticals - BIZNEWS",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Rare Disease Drug Market \u2013 Major Technology Giants in Buzz Again | Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Alexion Pharmaceuticals - BIZNEWS"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://biznews.co.ke/2020/12/14/rare-disease-drug-market-major-technology-giants-in-buzz-again-novartis-ag-eli-lilly-and-company-f-hoffmann-la-roche-ltd-bristol-myers-squibb-company-alexion-pharmaceuticals/"
      }
    ],
    "link": "https://biznews.co.ke/2020/12/14/rare-disease-drug-market-major-technology-giants-in-buzz-again-novartis-ag-eli-lilly-and-company-f-hoffmann-la-roche-ltd-bristol-myers-squibb-company-alexion-pharmaceuticals/",
    "id": "CBMizwFodHRwczovL2Jpem5ld3MuY28ua2UvMjAyMC8xMi8xNC9yYXJlLWRpc2Vhc2UtZHJ1Zy1tYXJrZXQtbWFqb3ItdGVjaG5vbG9neS1naWFudHMtaW4tYnV6ei1hZ2Fpbi1ub3ZhcnRpcy1hZy1lbGktbGlsbHktYW5kLWNvbXBhbnktZi1ob2ZmbWFubi1sYS1yb2NoZS1sdGQtYnJpc3RvbC1teWVycy1zcXVpYmItY29tcGFueS1hbGV4aW9uLXBoYXJtYWNldXRpY2Fscy_SAQA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:50:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      50,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://biznews.co.ke/2020/12/14/rare-disease-drug-market-major-technology-giants-in-buzz-again-novartis-ag-eli-lilly-and-company-f-hoffmann-la-roche-ltd-bristol-myers-squibb-company-alexion-pharmaceuticals/\" target=\"_blank\">Rare Disease Drug Market \u2013 Major Technology Giants in Buzz Again | Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Alexion Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BIZNEWS</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://biznews.co.ke/2020/12/14/rare-disease-drug-market-major-technology-giants-in-buzz-again-novartis-ag-eli-lilly-and-company-f-hoffmann-la-roche-ltd-bristol-myers-squibb-company-alexion-pharmaceuticals/\" target=\"_blank\">Rare Disease Drug Market \u2013 Major Technology Giants in Buzz Again | Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Alexion Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BIZNEWS</font>"
    },
    "source": {
      "href": "https://biznews.co.ke",
      "title": "BIZNEWS"
    },
    "sub_articles": []
  }
]